arsenic has been researched along with Carcinoma, Transitional Cell in 43 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (6.98) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 23 (53.49) | 29.6817 |
2010's | 13 (30.23) | 24.3611 |
2020's | 4 (9.30) | 2.80 |
Authors | Studies |
---|---|
Cedrone, F; Di Giovanni, P; Di Martino, G; Lucisano, G; Meo, F; Romano, F; Scampoli, P; Staniscia, T | 1 |
Chang, CW; Chen, YT; Cheng, PY; Huang, HC; Lee, HY; Li, CC; Lo, CW; Ou, CH; Tsai, CY; Wu, CC; Yu, CC | 1 |
Chung, CJ; Hsueh, YM; Huang, CY; Huang, YK; Lai, LA; Lin, YC; Pu, YS; Shiue, HS; Su, CT; Wu, CC | 1 |
Dalley, CD; Ezaydi, Y; Goepel, JR; Kirkbride, P; Krishna, R; Smith, DJ; Snowden, JA; Sorour, Y | 1 |
Cao, L; Dunlevy, JR; Garrett, SH; Sens, DA; Sens, MA; Somji, S; Zheng, Y; Zhou, XD | 1 |
Chen, J; Guan, JY; Hour, TC; Huang, CY; Lu, SH; Pu, YS | 2 |
Chen, YC; Christiani, DC; Guo, YL; Hsueh, YM; Lee, MS; Ryan, LM; Smith, TJ; Su, HJ | 1 |
Diwan, BA; Liu, J; Waalkes, MP | 1 |
Chen, CJ; Chen, SY; Hsu, LI; Hsueh, YM; Huang, YK; Huang, YL; Wu, MM; Yang, MH | 1 |
Bredfeldt, TG; Eblin, KE; Gandolfi, AJ | 1 |
Low-Beer, TS; Robertson, DA | 1 |
Atkinson, SC | 1 |
Bin, PJ; Chai, CY; Chang, SJ; Luo, CW | 1 |
Chang, CH; Chung, CJ; Chung, MC; Hsu, HT; Lee, HL; Liu, CS; Wu, CD | 1 |
Kao, YT; Lan, SH; Liu, HS; Tseng, YS; Wu, CH; Wu, SY | 1 |
Chen, CH; Dai, YC; Haque, MM; Lin, LC; Lin, WH; Liu, YW; Wang, SC | 1 |
Chang, YH; Pang, ST; Shao, IH | 1 |
Cherry, N; Mostafa, MG | 2 |
Chai, CY; Chen, YT; Liu, XP; Wu, CC | 1 |
Chen, CJ; Chiu, AW; Chung, CJ; Hsueh, YM; Huang, SK; Huang, YK; Pu, YS; Tsai, HJ; Yang, MH | 1 |
Chen, YT; Chung, CJ; Hsueh, YM; Huang, CJ; Huang, YK; Pu, YS; Su, CT | 1 |
Chen, CH; Chen, CJ; Chiou, HY; Hsueh, YM; Pu, YS; Yu, HJ | 1 |
Chen, HW; Chung, CJ; Hsueh, YM; Huang, YK; Pu, YS; Shiue, HS; Su, CT | 1 |
Chen, SC; Chen, WC; Chu, PY; Chung, TW; Kan, WC; Su, SB; Tan, LB; Tyan, YC; Wang, HY; Yang, MH | 1 |
Chen, SC; Chen, WC; Chung, TW; Jong, SB; Liao, PC; Tyan, YC; Yang, MH; Yang, YH | 1 |
Chung, CJ; Hsueh, YM; Huang, CY; Lee, HL; Lin, P; Pu, YS; Su, CT; Wu, CC | 1 |
Chung, CJ; Hsueh, YM; Huang, CY; Pu, YS; Shiue, HS; Su, CT | 1 |
Choe, YB; Park, JY; Rim, JH; Youn, JI | 1 |
Demidenko, E; Heaney, J; Karagas, MR; Morris, JS; Mott, LA; Schned, A; Tosteson, TD | 1 |
Chen, YC; Christiani, DC; Guo, YL; Houseman, EA; Su, HJ | 1 |
Chen, CJ; Chen, CL; Chen, CY; Chen, SY; Cheng, YC; Chiou, HY; Chou, WL; Hsu, LI; Hsu, YH; Hsueh, YM; Lee, CY; Lin, YC; Shih, WL; Tseng, MP; Wang, CH; Wang, LH; Wang, YH; Wu, MM | 1 |
Andrew, A; Danaee, H; Karagas, MR; Kelsey, KT; Liu, M; Marsit, CJ; Nelson, HH; Schned, A | 1 |
Garrett, SH; Namburi, VB; Sens, DA; Sens, MA; Singh, RK; Somji, S; Zhou, XD | 1 |
Chiou, SH; Chou, MC; Chow, KC; Huang, HH; Lin, TS; Lin, TY; Tai, HL | 1 |
Böcher, A; Buchter, A; Müller, M | 1 |
Chen, CJ; Chen, CL; Chiu, AW; Chou, WL; Hsieh, FI; Hsu, LI; Huan, SK; Wang, LH; Wang, YH | 1 |
Chen, CJ; Chiu, AW; Hsiao, CH; Hsieh, FI; Hsu, LI; Huan, SK; Pu, YS; Wang, YH | 1 |
Chen, CJ; Chiou, HY; Chiou, ST; Chou, YL; Hsu, YH; Tseng, CH; Wei, ML | 1 |
Cantor, KP | 1 |
Stöhrer, G | 1 |
Fujioka, H; Kaihara, H; Kitamura, K; Koh, E; Kondoh, N | 1 |
4 review(s) available for arsenic and Carcinoma, Transitional Cell
Article | Year |
---|---|
Arsenic Exposure and Risk of Urothelial Cancer: Systematic Review and Meta-Analysis.
Topics: Arsenic; Arsenicals; Carcinoma, Transitional Cell; Environmental Exposure; Humans; Observational Studies as Topic; Urologic Neoplasms | 2020 |
Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
Topics: Animals; Arsenicals; Carcinogens; Carcinoma, Transitional Cell; Cell Line, Transformed; Cell Transformation, Neoplastic; Humans; Models, Biological; Urinary Bladder Neoplasms; Urothelium | 2008 |
Recent advances in upper tract urothelial carcinomas: From bench to clinics.
Topics: Animals; Antineoplastic Agents; Aristolochic Acids; Arsenic; Carcinogens; Carcinoma, Transitional Cell; Disease Models, Animal; Drinking Water; Drugs, Chinese Herbal; Humans; Immunotherapy; Incidence; Kidney Neoplasms; Nephrectomy; Risk Factors; Taiwan; Ureteral Neoplasms; Ureteroscopy | 2019 |
Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan.
Topics: Arsenic; Biomarkers; Carcinoma, Transitional Cell; Carotenoids; Chromosome Aberrations; Environmental Monitoring; Genes, p53; Genomic Instability; Hair; Hazardous Substances; Humans; Loss of Heterozygosity; Mutation; Nails; Oxidative Stress | 2005 |
39 other study(ies) available for arsenic and Carcinoma, Transitional Cell
Article | Year |
---|---|
Comparative analysis of patients with upper urinary tract urothelial carcinoma in black-foot disease endemic and non-endemic area.
Topics: Aged; Arsenicals; Carcinoma, Transitional Cell; Disease-Free Survival; Endemic Diseases; Female; Geography; Humans; Incidence; Kidney Neoplasms; Male; Middle Aged; Peripheral Vascular Diseases; Prognosis; Retrospective Studies; Risk Factors; Taiwan; Ureteral Neoplasms; Water Pollution, Chemical | 2021 |
Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma.
Topics: Aged; Arsenicals; Carcinoma, Transitional Cell; Case-Control Studies; Dose-Response Relationship, Drug; Female; Genotype; Humans; Inflammation; Interleukin-6; Interleukin-8; Male; Methylation; Middle Aged; Polymorphism, Genetic; Regression Analysis; Risk; Socioeconomic Factors; Surveys and Questionnaires; Tumor Necrosis Factor-alpha; Urologic Neoplasms | 2013 |
Histopathological response of transitional cell carcinoma to arsenic trioxide during the treatment of concurrently diagnosed acute promyelocytic leukaemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carcinoma, Transitional Cell; Female; Humans; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasms, Multiple Primary; Oxides; Remission Induction; Tretinoin; Urinary Bladder Neoplasms | 2008 |
Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.
Topics: Animals; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Carcinogens; Carcinoma, Transitional Cell; Cell Line, Transformed; Cell Line, Tumor; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Keratin-6; Mice; Mice, Nude; Neoplasm Transplantation; Oxides; Urinary Bladder Neoplasms; Urothelium | 2010 |
Cytotoxicity of arsenic trioxide to transitional carcinoma cells.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Cisplatin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Glutathione; Humans; Oxides; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
Arsenic methylation and bladder cancer risk in Taiwan.
Topics: Aged; Arsenicals; Cacodylic Acid; Carcinoma, Transitional Cell; Case-Control Studies; Female; Humans; Male; Methylation; Middle Aged; Retrospective Studies; Risk Factors; Smoking; Taiwan; Urinary Bladder Neoplasms; Water Pollution, Chemical; Water Supply | 2003 |
Transplacental arsenic carcinogenesis in mice.
Topics: Animals; Anticarcinogenic Agents; Arsenic; Arsenicals; Carcinogens; Carcinoma, Transitional Cell; Data Interpretation, Statistical; Diethylstilbestrol; Dose-Response Relationship, Drug; Drug Synergism; Estrogens; Female; Gene Expression Regulation, Neoplastic; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C3H; Neoplasms; Pregnancy; Prenatal Exposure Delayed Effects; Signal Transduction; Skin Neoplasms; Tamoxifen; Tetradecanoylphorbol Acetate; Urinary Bladder Neoplasms | 2007 |
Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Topics: Adult; Aged; Arsenic; Arsenic Poisoning; Arsenicals; Cacodylic Acid; Carcinoma, Transitional Cell; Case-Control Studies; Chromatography, High Pressure Liquid; Cohort Studies; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Prospective Studies; Spectrophotometry, Atomic; Surveys and Questionnaires; Taiwan; Time Factors; Urinary Bladder Neoplasms | 2008 |
Long term consequences of arsenical treatment for multiple sclerosis.
Topics: Adult; Arsenic; Arsenic Trioxide; Arsenicals; Carcinoma, Transitional Cell; Humans; Hypertension, Portal; Male; Multiple Sclerosis; Oxides; Urinary Bladder Neoplasms | 1983 |
Arsenic trioxide as a novel anticancer agent against human transitional carcinoma--characterizing its apoptotic pathway.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Carcinoma, Transitional Cell; Caspase 3; Caspases; Cisplatin; DNA, Neoplasm; Drug Resistance, Neoplasm; Enzyme Activation; G1 Phase; Humans; Membrane Potentials; Mitochondria; Oxides; Reactive Oxygen Species; Signal Transduction; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2002 |
Arsenical keratoses and internal cancer (urinary bladder and nasopharynx).
Topics: Arsenicals; Carcinoma, Transitional Cell; Female; Humans; Keratosis; Middle Aged; Nasopharyngeal Neoplasms; Urinary Bladder Neoplasms | 1969 |
CHD4 plays a critical role in arsenite-induced oxidative damage in human urothelial carcinoma.
Topics: Arsenic; Arsenites; Carcinoma, Transitional Cell; DNA Damage; Humans; Mi-2 Nucleosome Remodeling and Deacetylase Complex; Oxidative Stress; Urinary Bladder Neoplasms | 2022 |
Determination of potential sources of heavy metals in patients with urothelial carcinoma in central Taiwan: a biomonitoring case-control study.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Arsenic; Biological Monitoring; Cadmium; Carcinoma, Transitional Cell; Case-Control Studies; Cobalt; Copper; Environmental Monitoring; Humans; Metals, Heavy; Nickel; Particulate Matter; Taiwan; Urinary Bladder Neoplasms | 2023 |
Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells.
Topics: Animals; Arsenic; Aurora Kinase A; Blotting, Western; Carcinogenesis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; E2F1 Transcription Factor; Flow Cytometry; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Reverse Transcriptase Polymerase Chain Reaction; Urinary Bladder Neoplasms | 2017 |
The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
Topics: Animals; Arsenic; Butylhydroxybutylnitrosamine; Carcinogenesis; Carcinogens; Carcinoma, Transitional Cell; Carrier Proteins; Cyclin-Dependent Kinase Inhibitor p21; Drug Interactions; Female; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Male; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); Sp1 Transcription Factor; Urinary Bladder; Urinary Bladder Neoplasms; Urothelium | 2017 |
Arsenic in drinking water and renal cancers in rural Bangladesh.
Topics: Adolescent; Adult; Aged; Arsenic; Bangladesh; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Drinking Water; Environmental Exposure; Female; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Risk Factors; Rural Population; Smoking; Surveys and Questionnaires; Water Pollutants, Chemical; Water Supply; Water Wells; Young Adult | 2013 |
Arsenic in Drinking Water, Transition Cell Cancer and Chronic Cystitis in Rural Bangladesh.
Topics: Arsenic; Bangladesh; Carcinoma, Transitional Cell; Chronic Disease; Cystitis; Drinking Water; Female; Humans; Logistic Models; Male; Neoplasms; Odds Ratio; Rural Population; Urologic Neoplasms; Water Supply; Water Wells | 2015 |
Aberrant β-catenin expression in urothelial carcinomas in blackfoot disease-endemic areas.
Topics: Aged; Antigens, CD; Arsenic; beta Catenin; Cadherins; Carcinoma, Transitional Cell; Cell Membrane; Cytosol; Endemic Diseases; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Proteins; Middle Aged; Protein Transport; Taiwan; Urologic Neoplasms; Urothelium; Water Pollutants, Chemical | 2017 |
Arsenic methylation capability, heme oxygenase-1 and NADPH quinone oxidoreductase-1 genetic polymorphisms and the stage and grade of urothelial carcinomas.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Arsenic; Arsenic Poisoning; Carcinoma, Transitional Cell; Cohort Studies; DNA Methylation; Environmental Exposure; Female; Humans; Incidence; Male; Middle Aged; NADH, NADPH Oxidoreductases; Neoplasm Staging; Polymorphism, Genetic; Probability; Prognosis; Risk Assessment; Survival Analysis; Taiwan; Urinary Bladder Neoplasms | 2008 |
Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Cyclin D; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Deoxyguanosine; Female; Genes, cdc; Genetic Variation; Humans; Male; Middle Aged; Polymorphism, Genetic; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms | 2008 |
Clinicopathological characteristics and survival outcome of arsenic related bladder cancer in taiwan.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Arsenic; Arsenic Poisoning; Carcinoma, Transitional Cell; Cohort Studies; Drinking; Environmental Exposure; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Probability; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Sex Factors; Survival Analysis; Taiwan; Urinary Bladder Neoplasms; Water Supply | 2009 |
Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma.
Topics: 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase; Aged; Arsenic; Cacodylic Acid; Carcinoma, Transitional Cell; Case-Control Studies; Cystathionine beta-Synthase; Female; Folic Acid; Genotype; Homocysteine; Humans; Life Style; Male; Metabolic Networks and Pathways; Methylation; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Socioeconomic Factors; Taiwan; Urinary Bladder Neoplasms | 2010 |
Characterization of ADAM28 as a biomarker of bladder transitional cell carcinomas by urinary proteome analysis.
Topics: ADAM Proteins; Aged; Aged, 80 and over; Amino Acid Sequence; Arsenic; Biomarkers, Tumor; Blotting, Western; Carcinoma, Transitional Cell; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Proteome; Proteomics; Urinary Bladder Neoplasms | 2011 |
Urinary protein profiling by liquid chromatography/tandem mass spectrometry: ADAM28 is overexpressed in bladder transitional cell carcinoma.
Topics: ADAM Proteins; Adult; Aged; Aged, 80 and over; Amino Acid Sequence; Arsenic; Biomarkers, Tumor; Carcinoma, Transitional Cell; Case-Control Studies; Chromatography, Liquid; Female; Humans; Male; Middle Aged; Molecular Sequence Data; Peptide Fragments; Peripheral Vascular Diseases; Proteinase Inhibitory Proteins, Secretory; Proteins; Proteinuria; Proteome; Proteomics; Reproducibility of Results; Sensitivity and Specificity; Serine Peptidase Inhibitor Kazal-Type 5; Taiwan; Tandem Mass Spectrometry; Urinary Bladder Neoplasms | 2011 |
Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma.
Topics: Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Humans; Methylation; Nitrosamines; Pyridines; Risk; Smoking; Urologic Neoplasms | 2012 |
The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype.
Topics: Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Chromatography, High Pressure Liquid; Environmental Exposure; Female; Genotype; Glutathione Transferase; Humans; Life Style; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Risk Factors; Smoking; Spectrophotometry, Atomic; Tobacco Smoke Pollution | 2013 |
Arsenic keratosis and pigmentation accompanied by multiple Bowen's disease and genitourinary cancer in a psoriasis patient.
Topics: Arsenic; Bowen's Disease; Carcinoma, Transitional Cell; Drug Therapy, Combination; Follow-Up Studies; Hand Dermatoses; Humans; Immunohistochemistry; Keratolytic Agents; Keratosis; Male; Middle Aged; Risk Assessment; Skin Neoplasms; Treatment Outcome; Urinary Bladder; Urogenital Neoplasms | 2002 |
Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire.
Topics: Adult; Aged; Arsenic; Carcinogens; Carcinoma, Transitional Cell; Case-Control Studies; Female; Humans; Incidence; Male; Middle Aged; New Hampshire; Odds Ratio; Registries; Smoking; Urinary Bladder Neoplasms; Water Supply | 2004 |
Interaction between environmental tobacco smoke and arsenic methylation ability on the risk of bladder cancer.
Topics: Aged; Air Pollutants; Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; Cataract; Environmental Pollutants; Female; Fractures, Bone; Humans; Inactivation, Metabolic; Male; Methylation; Middle Aged; Risk Factors; Sex Factors; Smoking; Taiwan; Tobacco Smoke Pollution; Urinary Bladder Neoplasms; Water Pollutants, Chemical | 2005 |
Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
Topics: Adult; Aged; Arsenic; Carcinoma, Transitional Cell; Cyclin-Dependent Kinase Inhibitor p16; DNA Methylation; Female; Gene Silencing; Genotype; Humans; Male; Middle Aged; New Hampshire; Polymerase Chain Reaction; Promoter Regions, Genetic; Smoking; Trypsin; Tumor Suppressor Protein p53; Tumor Suppressor Proteins; Urinary Bladder Neoplasms | 2006 |
Metallothionein-1 and -2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer.
Topics: Animals; Arsenic; Biomarkers, Tumor; Cadmium; Carcinoma, Transitional Cell; Cell Line, Transformed; Gene Expression Regulation, Neoplastic; Humans; Metallothionein; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Prognosis; RNA, Messenger; Urinary Bladder Neoplasms; Urothelium | 2006 |
Overexpression of aldo-keto reductase 1C2 as a high-risk factor in bladder cancer.
Topics: Adult; Arsenic; Carcinoma, Transitional Cell; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Hydroxysteroid Dehydrogenases; Immunohistochemistry; Male; Middle Aged; Phenotype; Risk; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Urinary Bladder Neoplasms | 2007 |
[Induction of urothelial carcinoma due to chronic arsenic ingestion? A occupational medicine-toxicological excursion].
Topics: Administration, Oral; Arsenic; Arsenic Poisoning; Carcinoma, Transitional Cell; Cross-Sectional Studies; Environmental Exposure; Germany; Humans; Kidney Neoplasms; Occupational Diseases; Occupational Exposure; Risk Factors; Urinary Bladder Neoplasms; Water Pollutants, Chemical | 2007 |
SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan.
Topics: Adult; Aged; Arsenic; Carcinoma, Transitional Cell; Case-Control Studies; DNA-Binding Proteins; Environmental Exposure; Epoxide Hydrolases; Female; Genetic Predisposition to Disease; Glutathione S-Transferase pi; Glutathione Transferase; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymorphism, Single Nucleotide; Risk Factors; Taiwan; Urologic Neoplasms; Water Pollutants, Chemical; X-ray Repair Cross Complementing Protein 1 | 2008 |
Comparative genomic hybridization study of arsenic-exposed and non-arsenic-exposed urinary transitional cell carcinoma.
Topics: Adult; Arsenic; Carcinoma, Transitional Cell; Chromosome Aberrations; Chromosomes, Human, Pair 17; DNA; Female; Gene Dosage; Genes, p53; Humans; Hybridization, Genetic; Immunohistochemistry; Male; Poisons; Regression Analysis; Smoking; Taiwan; Urinary Bladder Neoplasms; Water Supply | 2008 |
Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan.
Topics: Adult; Arsenic; Carcinoma, Transitional Cell; Cohort Studies; Dose-Response Relationship, Drug; Environmental Exposure; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Assessment; Taiwan; Urinary Bladder Neoplasms; Water Pollutants; Water Supply | 2001 |
Invited commentary: arsenic and cancer of the urinary tract.
Topics: Arsenic; Carcinoma, Transitional Cell; Cohort Studies; Humans; Prospective Studies; Risk Assessment; Urinary Bladder Neoplasms; Water Pollutants | 2001 |
Arsenic levels can be "standard" or "safe".
Topics: Arsenic; Arsenic Poisoning; Carcinoma, Transitional Cell; Drinking; Humans; Reproducibility of Results; Risk Assessment; United States; Urologic Neoplasms; Water; Water Supply | 2001 |
Ureteral tumor with multiple Bowen's disease forty-two years after exposure to arsenic.
Topics: Aged; Arsenic; Bowen's Disease; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Humans; Male; Occupational Diseases; Skin Neoplasms; Time Factors; Ureteral Neoplasms | 1989 |